Lupus drug showdown: which treatment works best?
NCT ID NCT07069972
First seen Feb 02, 2026 · Last updated Apr 28, 2026 · Updated 10 times
Summary
This study compares two drugs, telitacicept and belimumab, for people with systemic lupus erythematosus (SLE), a chronic autoimmune disease. Researchers want to see which drug better controls lupus symptoms and kidney problems. About 180 adults aged 18-65 will choose their treatment with their doctor. This is an observational study, meaning no one is assigned a drug—patients pick based on their needs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Qianfoshan Hospital
Jinan, Shandong, 250000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.